Eyesense Ag

Strategic Partnership to Develop and Commercialize a Novel Ophthalmic Self-Diagnostic System for Blood Glucose Monitoring by Diabetes Patients

Older News

BASEL, Switzerland, January 11, 2011 - EyeSense AG, a leading developer of novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients, today announced that it has entered into a strategic partnership with QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA).

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy